Click Therapeutics: Funding, Investors & Team (Sep 2026)
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
Click Therapeutics has raised $145M across 6 funding rounds on record, the most recent a Series D of $50.0M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Click Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Click Therapeutics Funding Rounds
1 of 6 rounds was announced without a disclosed amount and is excluded from the total.
Click Therapeutics raised $52.0M in a Series B announced in Oct 2021.
6 months later, a Debt Financing of $15.0M was announced in Apr 2022.
1.6 years later, an undisclosed round of $20.0M was announced in Nov 2023.
1 years later, an undisclosed round of $8.3M was announced in Nov 2024.
4 months later, a Series C was announced in Mar 2025 with no disclosed amount.
1.1 years later, a Series D of $50.0M was announced in Apr 2026.
Click Therapeutics Founders and Leadership Team
Contact details for the Click Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Click Therapeutics Funding Compared to Other Biotechnology Startups
Click Therapeutics' latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Click Therapeutics in Biotechnology and New York
Companies Similar to Click Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Click Therapeutics Funding FAQs
What does Click Therapeutics do?
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
How much funding has Click Therapeutics raised?
Click Therapeutics has raised $145M across 6 rounds on record. The most recent is a Series D of $50.0M announced in Apr 2026.
When did Click Therapeutics last raise funding?
Click Therapeutics' most recent funding round on record is a Series D of $50.0M, announced in Apr 2026.
Who founded Click Therapeutics?
FundedIQ lists David Benshoof (Founder) at Click Therapeutics.
Who is the CEO of Click Therapeutics?
David Benshoof Klein is listed as CEO at Click Therapeutics.
Where is Click Therapeutics headquartered?
Click Therapeutics is based in New York, United States.
How many employees does Click Therapeutics have?
Click Therapeutics is in the 101-250 employee band.
How does Click Therapeutics' funding compare to other Biotechnology startups?
Click Therapeutics' latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Click Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Click Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.